Skip to content

Prospective cohort study of long-term cardiovascular disease outcomes in menopausal obesity women with dampness syndrome

Prospective cohort study of long-term cardiovascular disease outcomes in menopausal obesity women with dampness syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062254
Enrollment
Unknown
Registered
2022-07-31
Start date
2022-07-31
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

menopausal obesity

Interventions

Case series:None

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincal Hospital of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for obesity. 2. Aged 40-60 years. 3. Late menopausal transition and postmenopausal women. 4. The patient entered the menopausal transition or began to develop obesity in the late menopause, and the BMI was normal during the reproductive age. 5. Sign the informed consent form and participate in the study voluntarily. 6. Any TCM syndrome type can be included, but the state of wet syndrome or non-wet syndrome should be judged when included.

Exclusion criteria

Exclusion criteria: 1. Obesity or drug-induced obesity secondary to endocrine diseases; 2. Female muscle obesity patients with body fat percentage < 30%; 3. Patients with unstable angina pectoris, acute myocardial infarction, coronary stent implantation or coronary artery bypass grafting have CVD endpoint outcomes; 4. Severe primary diseases such as liver and kidney insufficiency, hematopoietic system and malignant tumors; 5. Patients with carotid artery stenosis, transient ischemic attack, acute stroke, peripheral vascular disease; 6. Psychiatric patients (schizophrenia, mania, paranoid psychosis and depression with obvious suicidal tendencies); 7. Patients who are participating in other clinical studies; 8. Patients unwilling to cooperate with follow-up visits.

Design outcomes

Primary

MeasureTime frame
Physical examination (Waist circumference, hip circumference, height, weight, blood pressure, body fat ratio);Lipid metabolism;Gycometabolism;Sex hormone binding protein;Carotid plaque size;Metabonomics;Ten-year cardiovascular disease risk assessment;Menopausal symptom score;Cardiovascular end points (coronary heart disease, angina pectoris, stroke, etc.);Hyperlipidemia, diabetes, hypertension and other diseases happened in the cohort study;

Secondary

MeasureTime frame
Liver function;Renal function;Electrocardiogram;

Countries

China

Contacts

Public ContactNie Guangning

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincal Hospital of Chinese Medicine)

guangningnie@gzucm.edu.cn+86 13724078380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026